Actionable news
0
All posts from Actionable news
Actionable news in JAZZ: Jazz Pharmaceuticals plc,

Jazz Pharmaceuticals (JAZZ) Posts Q1 Earnings Beat, Updates 2016 Outlook

Shutterstock photo

Jazz Pharmaceuticals, Inc.

just released its first quarter fiscal 2016 earnings results, posting earnings of $1.87 per share and revenue of $336 million.

Currently, JAZZ has a Zacks Rank #3 (Hold), but it is subject to change following the release of the company's latest earnings report. Here are 5 key statistics from this just announced report below.

Jazz Pharmaceuticals:

1. Beat earnings estimates. The company posted earnings of $1.87 per share, surpassing the Zacks Consensus Estimate of $1.31 per share. This number excludes $0.68 from non-recurring items.

2. Missed revenue estimates. The company saw revenue figures of $336 million, missing our consensus estimate of $340 million but increasing 8.6% year-over-year.

3. Reported that net product sales increased by 9% to $333.9 million in the...


More